KL003 Cell Injection
CP-KL003-006/02
Unknown gene_therapy active
Quick answer
KL003 Cell Injection for Sickle Cell Disease is a Unknown program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Sickle Cell Disease
- Phase
- Unknown
- Modality
- gene_therapy
- Status
- active